VOTRIENT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VOTRIENT contains one active pharmaceutical ingredient (API):

1 Pazopanib UNII 33Y9ANM545 - PAZOPANIB HYDROCHLORIDE

Pazopanib is an orally administered, potent multi-target tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptors (VEGFR) -1, -2, and -3, platelet-derived growth factor (PDGFR) -α and -β, and stem cell factor receptor (c-KIT), with IC50 values of 10, 30, 47, 71, 84 and 74 nM, respectively. Read about Pazopanib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VOTRIENT Film-coated tablets	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EX03	Pazopanib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10041L, 10042M, 10043N, 10047T, 10052C, 10054E, 11252F, 11261Q, 2029T, 2030W, 2201W, 2232L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526517050089517, 526517050089617, 526517050089717
Country: CA	Health Products and Food Branch	Identifier(s): 02352303
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2776-MEE-0517
Country: EE	Ravimiamet	Identifier(s): 1482027, 1482038, 1482049, 1482050
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 10628001, 10628004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 058261, 085366
Country: FR	Base de données publique des médicaments	Identifier(s): 62894653, 63803884
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 174621, 174624
Country: HK	Department of Health Drug Office	Identifier(s): 60351, 60352, 62096, 62097
Country: IE	Health Products Regulatory Authority	Identifier(s): 88558, 88559
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6703, 6705
Country: IT	Agenzia del Farmaco	Identifier(s): 039945011, 039945023, 039945035, 039945047
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291028F1023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1055472, 1055473, 1055474, 1055475
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 174M2011
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 95265, 95273
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13984, 13985
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100222878, 100222884
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64502001, W64502002, W64503001, W64503002
Country: SG	Health Sciences Authority	Identifier(s): 14022P, 14023P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1243091, 1243092
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504092134, 8699504092141, 8699504092158, 8699504092165
Country: US	FDA, National Drug Code	Identifier(s): 0078-0670
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/26/0348, 44/26/0349